8

Listed companies

4

Private companies

25

Insiders

Relation chart of related listed companies: Mustang Bio, Inc.

Active Relations

Past Relations

Relationship chart for related private companies: Mustang Bio, Inc.

Active Relations

Past Relations

Related private companies: Mustang Bio, Inc.

Helocyte, Inc.

Miscellaneous Commercial Services

Cyprium Therapeutics, Inc.

Miscellaneous Commercial Services

Baergic Bio, Inc.

Pharmaceuticals: Major

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major8
Miscellaneous Commercial Services2
Medical Specialties1

Countries of related companies

United States11
Canada1
Logo Mustang Bio, Inc.
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR-T) therapies across multiple cancers, as well as lentiviral gene therapies for severe combined immunodeficiency. Its pipeline is focused in three core areas: CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors and gene therapies for rare genetic disorders. It is developing a CAR T therapy for hematologic malignancies in partnership with Fred Hutch targeting CD20 (MB-106). In partnership with St. Jude, its X-linked Severe Combined Immunodeficiency (XSCID) gene therapy programs (MB-117 and MB-217) are being developed under an exclusive license to develop a potentially curative treatment for XSCID, a rare genetic immune system condition.
Employees
80
More about the company